阿奇霉素联合特布他林治疗支原体肺炎的效果及对CRP、WBC的影响

Effect of Azithromycin combined with terbutaline in the treatment of mycoplasma pneumonia and its influence on CRP and WBC

目的探讨阿奇霉素联合特布他林治疗支原体肺炎的效果与安全性.方法选择本院治疗的84例支原体肺炎患儿.随机数字表法分组,各42例.患儿入院后立即给予常规治疗,在此基础上对照组采用阿奇霉素进行抗感染治疗,观察组在此基础上给予特布他林雾化吸入.对比两组患儿治疗效果以及CRP、WBC水平.结果观察组治疗效果(94.62%)显著优于对照组(78.57%)(P<0.05).观察组体温恢复正常时间、呼吸道症状及体征消退时间、X线阴影消退时间均显著少于对照组(P<0.05).观察组治疗7d后、治疗14d后WBC和CRP指标水平显著低于对照组,差异具有统计学意义(P<0.05).结论阿奇霉素+特布他林联合治疗支原体肺炎的疗效显著,可促进患儿炎症反应消退,缩短康复进程,安全可靠.

Objective To explore the efficacy and safety of Azithromycin combined with terbutaline in the treatment of mycoplasma pneumonia.Methods 84 children with mycoplasma pneumonia treated in our hospital from March 2018 to December 2019 were analyzed.They were randomly divided into two groups,42 cases in each group.On this basis,the control group was treated with azithromycin and the observation group was treated with terbutaline aerosol inhalation.The treatment effects and the levels of CRP and WBC were compared between the two groups.Results The therapeutic effect of the observation group(94.62%)was significantly better than that of the control group(78.57%)(P<0.05).The recovery time of body temperature,the regression time of respiratory symptoms and signs,and the regression time of X-ray shadow in the observation group were significantly shorter than those in the control group(P<0.05).The level of leukocyte count and CRP in the observation group was significantly lower than that in the control group(P<0.05).Conclusion The combination of azithromycin and terbutaline has a significant effect on Mycoplasma pneumoniae,which can promote the inflammatory reaction of children to subside,shorten the rehabilitation process,and is safe and reliable.